期刊文献+

去甲斑蝥素对人多发性骨髓瘤细胞株U266生长调控的影响及其机制的研究 被引量:6

EFFECT OF NORCANTHARIDIN ON THE GROWTH CONTROL OF HUMAN MYELOMA CELL LINE U266 AND ITS MECHANISM
下载PDF
导出
摘要 目的研究去甲斑蝥素(norcantharidin,NCTD)对多发性骨髓瘤细胞株的增殖及其凋亡的影响及其可能的机制。方法四甲基偶氮唑盐[3-(4,5-dimethyl-2 thiahiazoyi)-3,5-di-phenyl-tetrazolium bromide,MTT]检测5、20、40、80、160μmol/L的NCTD对U266细胞增殖的影响;用流式细胞术检测不同浓度NCTD对细胞周期及细胞凋亡的影响,并应用半定量反转录聚合酶链反应检测survivin基因表达的变化。结果在20~160μmol/L的浓度内,NCTD对U266细胞的增殖有抑制,抑制与NCTD的浓度呈剂量依赖关系(P<0.05)。不同浓度的NCTD能诱导多发性骨髓瘤细胞株U266凋亡,使细胞明显阻滞于G_2/M期;在NCTD作用下,U266细胞survivin及其机制可能与诱导凋亡、细胞周期阻滞有关。结论 NCTD能抑制U266细胞的增殖,并诱导其凋亡的机制可能与抑制survivin的表达及G_2/M期阻滞有关。 Objective To study the inhibitory effect of norcantharidin(NCTD) on the growth of human myeloma cell line U266 . Methods U266 cells were treated with different concentrations of NCTD . The growth of U266 cells was measured by MTF(3 , (4,5-dimethyl -2 thiahiazoyi) -3,5 -di - phenyl - tetrazolium bromide ), and changes of apoptosis rate and cell cycle by flow cytometry. Semiquantitative reverse transcription - polymerase chain reaction was used to detect the effect of NCTD on survivin gene expression. Results Within the concentrations of 20 - 160p, mol/L, NCTD can obviously inhibited the growth of U266 cells in a dose - dependent manner. NCTD can increase Annexin V positive rate, block cell at G2/M phase, reduce the gene expression of survivin . Conclusion NCTD can inhibit the growth of U266 cells in a dose - dependent manner and inhibit survivin gene expression . The mechanism is probably related to apoptosis induction and cell cycle arrest in G2/M phase.
出处 《河北医科大学学报》 CAS 2010年第8期896-899,I0001,共5页 Journal of Hebei Medical University
基金 河北省中医药局课题(2007136)
关键词 去甲斑蝥素 多发性骨髓瘤 细胞 凋亡 norcantharidin multiple myeloma apoptosis
  • 相关文献

参考文献13

二级参考文献51

共引文献32

同被引文献37

  • 1Fan, Yue-Zu,Fu, Jin-Ye,Zhao, Ze-Ming,Chen, Chun-Qiu.Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):72-80. 被引量:25
  • 2Huang Y, Liu Q, Liu K, et al. Suppression of growth of highly- metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology, 2009, 59: 201-205.
  • 3Liu FY, Li Y, Peng YM, et al. Norcantharidin ameliorates pro- teinuria, associated tubulointerstitial inflammation and fibrosis in protein overload nephropathy. Am J Nephrol, 2008, 28: 465- 477.
  • 4Baumann P, Mandl-Weber S, Oduncu F, et al. Alkylating agents induce activation of NFkappaB in multiple myeloma cells. Leuk Res, 2008, 32: 1144-1147.
  • 5Kaspers GJ, Veerman AJ, Pieters R, et al. Drug combination tes- ting in acute lymphoblastic leukemia using the MTY assay. Leuk Res, 1995, 19: 175-181.
  • 6Hideshima T, Bergsagel PL, Kuehl WM, et al. Advances in biol- ogy of muhiple myeloma : clinical applications. Blood, 2004, 104 : 607-618.
  • 7Sung B, Kunnumakkara AB, Sethi G, et al. Curcumin circum- vents chemoresistance in vitro and potentiates the effect of thalido- mide and bortezomib against human muhiple myeloma in nude mice model. Mol Cancer Ther, 2009, 8 : 959-970.
  • 8Thees S, Hubbard GB, Winckler J, et al. Specific alteration of the Bax/Bcl2 ratio and eytochrome c without execution of apopto- sis in the hippocampus of aged baboons. Restor Neurol Neurosci, 2005, 23 : 1-9.
  • 9Li F, Ling X. Survivin study: an update of "What is the next wave?". J Cell Physiol, 2006, 208 : 476-486.
  • 10Romagnoli M, S6veno C, Wuilleme-Toumi S, et al. The imbal- ance between Survivin and Bim mediates tumour growth and cor- relates with poor survival in patients with multiple myeloma. Br J Haematol, 2009, 145 : 180-189.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部